Skip to main content
Fig. 9 | Human Genomics

Fig. 9

From: Identification of subgroups along the glycolysis-cholesterol synthesis axis and the development of an associated prognostic risk model

Fig. 9

The comparison between our model and Liao’s immune-related model. A Kaplan-Meier curve for Liao’s immune-related model in GSE19234 (n = 44). The clinical outcome endpoint was OS. B The ROC curve of 5-year follow-up time for our model and Liao’s immune-related model in GSE19234 (n = 44). AUC, area under curve; OS, overall survival. And P < 0.05 is defined as statistically significant

Back to article page

Human Genomics

ISSN: 1479-7364